A carregar...
Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway
BACKGROUND: CD300A, a type I transmembrane glycoprotein receptor, plays an important role in immune response. Recent studies have reported that CD300A is involved in the development of hematological malignancies. PURPOSE: The objective of this study was to investigate the role of CD300A in the progr...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6290927/ https://ncbi.nlm.nih.gov/pubmed/30573974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S185521 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|